AI assistant
Sartorius Stedim Biotech — Director's Dealing 2020
Nov 2, 2020
1645_iss_2020-11-02_247533c0-dd1b-4652-9313-1e580a60fdef.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them
1. Contact information for the person discharging managerial responsibilities or the closely related person
Company name: Sartorius AG Legal form: AG (Aktiengesellschaft)
2. Reason for notification
The declarant is a closely related person referred to in Article 3.26) of EU Regulation 596/2014 of April 16, 2014 on market abuse.
Please specify the positions held within the issuer.
Positions: i. Joachim Kreuzburg is chairman and CEO of Sartorius Stedim Biotech SA and chairman of the management board of Sartorius AG; ii. Dr. René Fáber is a member of the board of Sartorius Stedim Biotech SA and a member of the management board of Sartorius AG; iii. Dr. Lothar Kappich is a member of the board of Sartorius Stedim Biotech SA and chairman of the supervisory board of Sartorius AG.
This is an initial notification.
3. Contact information of the issuer
Company name: Sartorius Stedim Biotech S.A. LEI: 52990006IVXY7GCSSR39
4. Information about the transaction
Date of the transaction: 02/11/2020 Place of the transaction: outside a trading venue Nature of the transaction: sale Description of the financial instrument: shares Identification code: FR0013154002
Detailed information by transaction: Unit price: EUR 327.00 Volume: 405,887 shares
Aggregated information: Weighted average price: EUR 327.00 Volume: 405,887 shares
The transaction is NOT related to the exercise of a stock option program or to a bonus or performance share grant.
5. Comments
Ø